Brii Biosciences HBV therapy - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

VA Tech Wabag (NSE: WABAG) wins order from CMWSSB for 45 MLD Chennai TTRO plant

Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway

Representative image of enterprise cloud cybersecurity infrastructure illustrating how Accenture plc and Google Cloud are strengthening cloud security defenses against AI-driven cyber threats and multi-cloud security risks.

How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure

Four-decade-first: Lok Sabha votes down no-confidence motion against Speaker Om Birla

Brii Biosciences receives Breakthrough Therapy Designations for BRII-877 and BRII-835, advancing HBV treatment options.

Read More

2 minute read

Pharma Industry News

Brii Biosciences receives breakthrough therapy designations for HBV treatments

Brii Biosciences Limited, a biotechnology company developing therapies for diseases with high unmet need, announced that the Center…

byPallavi Madhiraju

May 14, 2024

web analytics